155 related articles for article (PubMed ID: 2445212)
1. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
[TBL] [Abstract][Full Text] [Related]
2. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). II. Use of compounds of the muramyl dipeptide (MDP) family as adjuvants.
Nash HA; Chang CC; Tsong YY
J Reprod Immunol; 1985 Feb; 7(2):151-62. PubMed ID: 3981488
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
Talwar GP; Singh O; Singh V; Rao DN; Sharma NC; Das C; Rao LV
Fertil Steril; 1986 Jul; 46(1):120-6. PubMed ID: 2424791
[TBL] [Abstract][Full Text] [Related]
4. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). IV. The role of adjuvants in booster injections.
Chang CC; Nash HA; Tsong YY
J Reprod Immunol; 1986 Dec; 9(4):327-37. PubMed ID: 2434651
[TBL] [Abstract][Full Text] [Related]
5. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). III. Evaluation of various vehicles and adjuvants.
Chang CC; Tsong YY; Nash HA
J Reprod Immunol; 1985 Feb; 7(2):163-9. PubMed ID: 3981489
[TBL] [Abstract][Full Text] [Related]
6. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). I. Alternative macromolecular carriers.
Tsong YY; Chang CC; Nash HA
J Reprod Immunol; 1985 Feb; 7(2):139-49. PubMed ID: 3981487
[TBL] [Abstract][Full Text] [Related]
7. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid.
Nash H; Johansson ED; Talwar GP; Vasquez J; Segal S; Coutinho E; Luukkainen T; Sundaram K
Fertil Steril; 1980 Oct; 34(4):328-35. PubMed ID: 7418885
[TBL] [Abstract][Full Text] [Related]
8. Role of muramyl peptides for the enhancement of synthetic vaccines.
Chedid L; Audibert F; Jolivet M
Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of a World Health Organisation birth control vaccine.
Jones WR; Bradley J; Judd SJ; Denholm EH; Ing RM; Mueller UW; Powell J; Griffin PD; Stevens VC
Lancet; 1988 Jun; 1(8598):1295-8. PubMed ID: 2453766
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of adjuvanticity of promising new synthetic MDP analogues.
Alam A; Capoor AK; Rao LV
Immunol Lett; 1991 Jan; 27(1):53-7. PubMed ID: 2019420
[TBL] [Abstract][Full Text] [Related]
11. Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin.
Stevens VC
Ciba Found Symp; 1986; 119():200-25. PubMed ID: 2426053
[TBL] [Abstract][Full Text] [Related]
12. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine.
Dirnhofer S; Klieber R; De Leeuw R; Bidart JM; Merz WE; Wick G; Berger P
FASEB J; 1993 Nov; 7(14):1381-5. PubMed ID: 7693535
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for control of fertility and hormone dependent cancers.
Talwar GP; Singh O; Pal R; Chatterjee N
Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
[TBL] [Abstract][Full Text] [Related]
14. Contraception.
Jones WR
Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):629-40. PubMed ID: 1446424
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in immunocontraception.
Talwar GP; Gaur A
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1075-8. PubMed ID: 2445210
[TBL] [Abstract][Full Text] [Related]
16. The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine.
Talwar GP; Singh OM; Gupta SK; Hasnain SE; Pal R; Majumbar SS; Vrati S; Mukhopadhay A; Srinivasan J; Deshmukh U; Ganga S; Mandokhot A; Gupta A
Am J Reprod Immunol; 1997 Feb; 37(2):153-60. PubMed ID: 9083611
[TBL] [Abstract][Full Text] [Related]
17. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormone.
Talwar GP; Singh O; Rao LV
J Reprod Immunol; 1988 Dec; 14(3):203-12. PubMed ID: 3147333
[TBL] [Abstract][Full Text] [Related]
18. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (beta hCG) and beta hCG associated with the alpha subunit of ovine luteinizing hormone linked to carriers.
Pal R; Singh O; Rao LV; Talwar GP
Am J Reprod Immunol; 1990; 22(3-4):124-6. PubMed ID: 1695850
[TBL] [Abstract][Full Text] [Related]
19. Anti-fertility vaccines.
Talwar GP; Raghupathy R
Vaccine; 1989 Apr; 7(2):97-101. PubMed ID: 2665354
[TBL] [Abstract][Full Text] [Related]
20. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin.
Singh O; Rao LV; Gaur A; Sharma NC; Alam A; Talwar GP
Fertil Steril; 1989 Nov; 52(5):739-44. PubMed ID: 2806615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
